Search Results - "Ruehle, Kathy"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A

    Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A by Sarkodee-Adoo, Clarence, Sotirescu, Dan, Sensenbrenner, Lyle, Rapoport, Aaron P., Cottler-Fox, Michele, Tricot, Guido, Ruehle, Kathy, Meisenberg, Barry

    Published in Transfusion (Philadelphia, Pa.) (01-01-2003)
    “…BACKGROUND : Cyclosporine A (CSA) and tacrolimus (FK‐506) are both associated with thrombotic microangiopathy (TMA) in allogeneic BMT recipients, although it…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts)

    Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts) by Badros, Ashrof Z., Bolaños-Meade, Javier, Rapoport, Aaron, Ratterree, Bashi, Natt, Sabrina, Ruehle, Kathy, McNamara, Kathy, Cox, Edmund, Westphal, Sandy, Fenton, Robert, Meisenberg, Barry

    Published in Blood (16-11-2004)
    “…In vitro data suggest that the addition of bortezomib to chemotherapy can enhance the anti-myeloma activity achieved with either therapy alone. We hypothesized…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: